Practical strategies for management of fatigue and sleep disorders in people with brain tumors

Neuro-Oncology

Volumn 14, Issue SUPPL.4, 2012, Pages

  Armstrong, Terri S ^a,b   Gilbert, Mark R ^b  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT HOUSTON   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

brain tumor; fatigue; sleep

Indexed keywords

ESZOPICLONE; FLURAZEPAM; LORAZEPAM; RAMELTEON; TEMAZEPAM; TRIAZOLAM; ZALEPLON; ZOLPIDEM TARTRATE;

ACTIMETRY; ADDICTION; AMNESIA; ARTICLE; BRAIN RADIATION; BRAIN TUMOR; COGNITIVE THERAPY; DAYTIME SOMNOLENCE; DRUG MECHANISM; EXERCISE; FATIGUE; GLIOBLASTOMA; HANGOVER; HUMAN; INSOMNIA; SEDATION; SIDE EFFECT; SLEEP DISORDER; SLEEP WAKING CYCLE;

BRAIN NEOPLASMS; FATIGUE; HUMANS; SLEEP DISORDERS;

EID: 84868006044     PISSN: 15228517     EISSN: 15235866     Source Type: Journal    
DOI: 10.1093/neuonc/nos210     Document Type: Article

References (61)

1. Fiorentino L, Rissling M, Liu L, et al. The Symptom Cluster of Sleep, Fatigue and Depressive Symptoms in Breast Cancer Patients: Severity of the Problem and Treatment Options. Drug Discov Today Dis Models. 8(4):167-173.
2. Clevenger L, Schrepf A, Christensen D, et al. Sleep disturbance, cyto-kines, and fatigue in women with ovarian cancer. [published online ahead of print April 21, 2012]. Brain Behav Immun. doi:10.1016/j.bbi.2012.04.003.
3. Cleeland CS, Bennett GJ, Dantzer R, et al. Are the symptoms of cancer and cancer treatment due to a shared biologic mechanism? A cytokine-immu-nologic model of cancer symptoms. Cancer. 2003;97(11):2919-2925. (Pubitemid 36605163)
4. Banthia R, Malcarne VL, Ko CM, et al. Fatigued breast cancer survivors: the role of sleep quality, depressed mood, stage and age. Psychol Health. 2009;24(8):965-980.
5. Zee PC, Ancoli-Israel S. Does effective management of sleep disorders reduce cancer-related fatigue? Drugs. 2009;69(Suppl 2):29-41.
6. Stepanski EJ, Walker MS, Schwartzberg LS, et al. The relation of trouble sleeping, depressed mood, pain, and fatigue in patients with cancer. J Clin Sleep Med. 2009;5(2):132-136.
7. Savard J, Morin CM. Insomnia in the context of cancer: a review of a neglected problem. J Clin Oncol. 2001;19(3):895-908. (Pubitemid 32119105)
8. Mendoza TR, Wang XS, Cleeland CS, et al. The rapid assessment of fatigue severity in cancer patients: use of the Brief Fatigue Inventory. Cancer. 1999;85(5):1186-1196. (Pubitemid 29115600)
9. Barsevick AM, Cleeland CS, Manning DC, et al. ASCPRO recommendations for the assessment of fatigue as an outcome in clinical trials. J Pain Symptom Manage. 2010;39(6):1086-1099.
10. Armstrong TS, Cron SG, Bolanos EV, et al. Risk factors for fatigue severity in primary brain tumor patients. Cancer. 116(11):2707-2715.
11. Lovely MP, Miaskowski C, Dodd M. Relationship between fatigue and quality of life in patients with glioblastoma multiformae. Oncol Nurs Forum. 1999;26(5):921-925.
12. Powell C, Guerrero D, Sardell S, et al. Somnolence syndrome in patients receiving radical radiotherapy for primary brain tumours: a prospective study. Radiother Oncol. 100(1):131-136.
13. Drappatz J, Schiff D, Kesari S, et al. Medical management of brain tumor patients. Neurol Clin. 2007;25(4):1035-71, ix. (Pubitemid 47610811)
14. Faithfull S, Brada M. Somnolence syndrome in adults following cranial irradiation for primary brain tumours. Clin Oncol (R Coll Radiol). 1998;10(4):250-254. (Pubitemid 28454546)
15. Struik K, Klein M, Heimans JJ, et al. Fatigue in low-grade glioma. J Neurooncol. 2009;92(1):73-78.
16. Rooney AG, Carson A, Grant R. Depression in cerebral glioma patients: a systematic review of observational studies. J Natl Cancer Inst. 2011;103(1):61-76.
17. Berger AM, Parker KP, Young-McCaughan S, et al. Sleep wake disturbances in people with cancer and their caregivers: state of the science. Oncol Nurs Forum. 2005;32(6):E98-126.
18. Janz NK, Mujahid M, Chung LK, et al. Symptom experience and quality of life of women following breast cancer treatment. J Womens Health (Larchmt). 2007;16(9):1348-1361. (Pubitemid 350125860)
19. Miaskowski C, Lee K, Dunn L, et al. Sleep-wake circadian activity rhythm parameters and fatigue in oncology patients before the initiation of radiation therapy. Cancer Nurs. 34(4):255-268.
20. Gapstur R, Gross CR, Ness K. Factors associated with sleep-wake disturbances in child and adult survivors of pediatric brain tumors: a review. Oncol Nurs Forum. 2009;36(6):723-731.
21. Schutte-Rodin S, Broch L, Buysse D, et al. Clinical guideline for the evaluation and management of chronic insomnia in adults. J Clin Sleep Med. 2008;4(5):487-504.
22. Kurzrock R. The role of cytokines in cancer-related fatigue. Cancer. 2001;92(6 Suppl):1684-1688. (Pubitemid 32939175)
23. Rich T, Innominato PF, Boerner J, et al. Elevated serum cytokines correlated with altered behavior, serum cortisol rhythm, and dampened 24-hour rest-activity patterns in patients with metastatic colorectal cancer. Clin Cancer Res. 2005;11(5):1757-1764. (Pubitemid 40471837)
24. Scheff JD, Calvano SE, Lowry SF, et al. Modeling the influence of circa-dian rhythms on the acute inflammatory response. J Theor Biol. 264(3):1068-1076.
25. Hrushesky WJ, Grutsch J, Wood P, et al. Circadian clock manipulation for cancer prevention and control and the relief of cancer symptoms. Integr Cancer Ther. 2009;8(4):387-397.
26. Page GG, Ben-Eliyahu S. The immune-suppressive nature of pain. Semin Oncol Nurs. 1997;13(1):10-15.
27. Srinivasan V, Spence DW, Pandi-Perumal SR, et al. Therapeutic actions of melatonin in cancer: possible mechanisms. Integr Cancer Ther. 2008;7(3):189-203.
28. Armstrong TS, Acuaye A, Vera-Bolanos E, et al. QL-02. Biologic correlates of fatigue in glioma patients undersgoing radiation therapy. Neuro-Oncology. 2010;12(Suppl 4):99-105.
29. Muller HL, Handwerker G, Wollny B, et al. Melatonin secretion and increased daytime sleepiness in childhood craniopharyngioma patients. J Clin Endocrinol Metab. 2002;87(8):3993-3996. (Pubitemid 34879560)
30. Wion D, Berger F. Wion-Barbot N. Glioma, melatonin, and radiotherapy. Cancer Res. 2006;66(12):6457.
31. Kassayova M, Ahlersova E, Ahlers I. Two-phase response of rat pineal melatonin to lethal whole-body irradiation with gamma rays. Physiol Res. 1999;48(3):227-230. (Pubitemid 29317820)
32. Ozkan E, Yaman H, Cakir E, et al. Plasma Melatonin and Urinary 6-Hydroxymelatonin Levels in Patients with Pulmonary Tuberculosis. Inflammation.
33. Bagci S, Yildizdas D, Horoz OO, et al. Use of nocturnal melatonin concentration and urinary 6-sulfatoxymelatonin excretion to evaluate mel-atonin status in children with severe sepsis. J Pediatr Endocrinol Metab. 24(11-12):1025-1030.
34. Riccitelli G, Rocca MA, Forn C, et al. Voxelwise assessment of the regional distribution of damage in the brains of patients with multiple sclerosis and fatigue. AJNR Am J Neuroradiol. 2011;32(5):874-879.
35. Agasi-Idenburg C, Velthuis M, Wittink H. Quality criteria and user-friendliness in self-reported questionnaires on cancer-related fatigue: a review. J Clin Epidemiol. 2010;63(7):705-711.
36. Barsevick A, Beck SL, Dudley WN, et al. Efficacy of an intervention for fatigue and sleep disturbance during cancer chemotherapy. J Pain Symptom Manage. 2010;40(2):200-216.
37. Piper BF, Dibble SL, Dodd MJ, et al. The revised Piper Fatigue Scale: psychometric evaluation in women with breast cancer. Oncol Nurs Forum. 1998;25(4):677-684.
38. Lai JS, Cella D, Choi S, et al. How item banks and their application can influence measurement practice in rehabilitation medicine: a PROMIS fatigue item bank example. Arch Phys Med Rehabil. 92(Suppl 10):S20-27.
39. Philip J, Smith WB, Craft P, et al. Concurrent validity of the modified Edmonton Symptom Assessment System with the Rotterdam Symptom Checklist and the Brief Pain Inventory. Support Care Cancer. 1998;6(6):539-541. (Pubitemid 28520469)
40. Armstrong TS, Mendoza T, Gning I, et al. Validation of the M.D. Anderson Symptom Inventory Brain Tumor Module (MDASI-BT). J Neurooncol. 2006;80(1):27-35. (Pubitemid 44473259)
41. Johns MW. A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep. 1991;14(6):540-545.
42. Backhaus J, Junghanns K, Broocks A, et al. Test-retest reliability and validity of the Pittsburgh Sleep Quality Index in primary insomnia. J Psychosom Res. 2002;53(3):737-740.
43. Beck SL, Schwartz AL, Towsley G, et al. Psychometric evaluation of the Pittsburgh Sleep Quality Index in cancer patients. J Pain Symptom Manage. 2004;27(2):140-148. (Pubitemid 38221072)
44. Noda A. [Self-report assessment: questionnaires and sleep logs/diaries]. Nihon Rinsho. 2009;67(8):1553-1562.
45. Rogers AE, Caruso CC, Aldrich MS. Reliability of sleep diaries for assessment of sleep/wake patterns. Nurs Res. 1993;42(6):368-372.
46. Ancoli-Israel S, Cole R, Alessi C, et al. The role of actigraphy in the study of sleep and circadian rhythms. Sleep. 2003;26(3):342-392. (Pubitemid 39610685)
47. Littner M, Hirshkowitz M, Davila D, et al. Practice parameters for the use of auto-titrating continuous positive airway pressure devices for titrating pressures and treating adult patients with obstructive sleep apnea syndrome. An American Academy of Sleep Medicine report. Sleep. 2002;25(2):143-147. (Pubitemid 34193576)
48. Monk TH, Reynolds CF, Kupfer DJ, et al. The Pittsburgh Sleep Diary. J Sleep Res. 1994;3(2):111-120. (Pubitemid 24173501)
49. Network N.C.C. NCCN Guidelines Version 1. 2012 Cancer-Related Fatigue. Fort Washington, PA: NCCN, 2011.
50. Cramp F, Daniel J. Exercise for the management of cancer-related fatigue in adults. Cochrane Database Syst Rev. 2008;2(2):CD006145.
51. Kemp BA, Gora ML. Amantadine and fatigue of multiple sclerosis. Ann Pharmacother. 1993;27(7-8):893-895. (Pubitemid 23225680)
52. Seppi K, Weintraub D, Coelho M, et al. The Movement Disorder Society Evidence-Based Medicine Review Update: Treatments for the nonmotor symptoms of Parkinson's disease. Mov Disord. 2011;26(Suppl 3):S42-S80.
53. Kangas M, Bovbjerg DH, Montgomery GH. Cancer-related fatigue: a systematic and meta-analytic review of non-pharmacological therapies for cancer patients. Psychol Bull. 2008;134(5):700-741.
54. Goedendorp MM, Gielissen MF, Verhagen CA, et al. Severe fatigue and related factors in cancer patients before the initiation of treatment. Br J Cancer. 2008;99(9):1408-1414.
55. Minton O, Richardson A, Sharpe M, et al. Psychostimulants for the management of cancer-related fatigue: a systematic review and meta-analysis. J Pain Symptom Manage. 41(4):761-767.
56. Moraska AR, Sood A, Dakhil SR, et al. Phase III, randomized, doubleblind, placebo-controlled study of long-acting methylphenidate for cancer-related fatigue: North Central Cancer Treatment Group NCCTG-N05C7 trial. J Clin Oncol. 28(23):3673-3679.
57. Kronenberger B, Berg T, Herrmann E, et al. Efficacy of amantadine on quality of life in patients with chronic hepatitis C treated with interferon-alpha and ribavirin: results from a randomized, placebo-controlled, double-blind trial. Eur J Gastroenterol Hepatol. 2007;19(8):639-646. (Pubitemid 47067061)
58. Morgenthaler T, Kramer M, Alessi C, et al. Practice parameters for the psychological and behavioral treatment of insomnia: an update. An american academy of sleep medicine report. Sleep. 2006; 29(11):1415-1419. (Pubitemid 44764666)
59. Berger AM. Update on the state of the science: sleep-wake disturbances in adult patients with cancer. Oncol Nurs Forum. 2009; 36(4):E165-177.
60. Jacobsen PB, Massie MJ, Kinne DW, et al. Hypnotic efficacy and safety of triazolam administered during the postoperative period. Gen Hosp Psychiatry. 1994;16(6):419-425. (Pubitemid 24355868)
61. Budur K, Rodriguez C, Foldvary-Schaefer N. Advances in treating insomnia. Cleve Clin J Med. 2007;74(4):251-2. 255-8, 261-2 passim.